Global Naloxone Spray Market Product Type (2 mg/Spray, 4 mg/Spray, 8 mg/Spray) By Distribution Channel(Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others, By End User( Hospitals, Emergency Medical Services, Home Care Settings, Community Organizations, Others) By Application(Opioid Overdose Reversal, Emergency Use, Personal Use, Others), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035
- Published date: May 2026
- Report ID: 185562
- Number of Pages: 379
- Format:
-
keyboard_arrow_up
-
-
- Emergent BioSolutions Inc.
- Pfizer Inc.
- Adapt Pharma Inc.
- Opiant Pharmaceuticals Inc.
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Sandoz International GmbH
- Hikma Pharmaceuticals PLC
- Kaleo Inc.
- Amphastar Pharmaceuticals Inc.
- West-Ward Pharmaceuticals Corp.
- Indivior PLC
- BioDelivery Sciences International Inc.
- Lightlake Therapeutics Inc.
- Aquestive Therapeutics Inc.
- Others
Our Clients
- 185562
- May 2026
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
